HRES 1125 · 116th Congress 2019–2021, ended

Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.

Introduced Sep 18, 2020 Originated House Sponsor Eliot L. Engel D-NY

Fact sheet Spreadsheet

Latest action · Sep 18, 2020 Referred to the House Committee on Energy and Commerce.

Progress

Where this resolution reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried. A simple resolution is the business of one chamber alone: it is not sent to the other chamber or to the President, and does not become law.

  1. IntroducedSep 18, 2020
  2. Agreed to in HouseNot reached

Summary

This resolution expresses the sense of the House of Representatives that federal agencies should take appropriate actions to (1) ensure meaningful engagement of communities of color in the conduct of COVID-19 (i.e., coronavirus disease 2019) research and participation in clinical trials, and (2) improve equitable access to safe and effective vaccines.

Cosponsors 22

Members who signed on, in the order they did. Signatures ran from Sep 18, 2020 to Sep 30, 2020; 19 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NYAdriano EspaillatOriginalSep 18, 2020
D-NJAlbio SiresOriginalSep 18, 2020
D-CAAmi BeraOriginalSep 18, 2020
D-CABarbara LeeOriginalSep 18, 2020
D-NCDavid E. PriceOriginalSep 18, 2020
D-MDDavid J. TroneOriginalSep 18, 2020
D-NJDonald M. Payne, Jr.OriginalSep 18, 2020
D-TXEddie Bernice JohnsonOriginalSep 18, 2020
D-DCEleanor Holmes NortonOriginalSep 18, 2020
D-CAGilbert Ray Cisneros, Jr.OriginalSep 18, 2020
D-NYGregory W. MeeksOriginalSep 18, 2020
D-CTJahana HayesOriginalSep 18, 2020
D-MAJames P. McGovernOriginalSep 18, 2020
D-NYJerrold NadlerOriginalSep 18, 2020
D-GUMichael F. Q. San NicolasOriginalSep 18, 2020
D-CANanette Diaz BarragánOriginalSep 18, 2020
D-TXSheila Jackson LeeOriginalSep 18, 2020
D-TNSteve CohenOriginalSep 18, 2020
D-ALTerri A. SewellOriginalSep 18, 2020
D-TXJoaquin CastroSep 23, 2020
D-VAElaine G. LuriaSep 30, 2020
D-CAJudy ChuSep 30, 2020

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Sep 18, 2020

Actions 2

Everything that happened, newest first.

  1. Sep 18, 2020Introduced in House
  2. Sep 18, 2020Referred to the House Committee on Energy and Commerce.

Titles 1

Every title it has carried, official and short, at each stage.

Official Title as Introduced
Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Sep 18, 2020Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this resolution on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.